Founders Grove Wealth Partners’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$485K Buy
5,342
+145
+3% +$13.2K 0.1% 111
2026
Q1
$534K Buy
5,197
+231
+5% +$26.1K 0.12% 96
2025
Q4
$622K Buy
4,966
+308
+7% +$39.2K 0.14% 90
2025
Q3
$624K Buy
4,658
+319
+7% +$41.9K 0.15% 91
2025
Q2
$590K Buy
4,339
+160
+4% +$21.1K 0.15% 87
2025
Q1
$554K Buy
4,179
+15
+0.4% +$1.91K 0.15% 86
2024
Q4
$471K Buy
+4,164
New +$481K 0.14% 87

Other funds holding ABT

Founders Grove Wealth Partners's ABT Position: Q2 2026 in Review

Founders Grove Wealth Partners increased its Abbott (ABT) stake by 2.8% in Q2 2026, buying an estimated $13.2K and bringing the position to 5,342 shares worth $485K. The position accounts for 0.1% of the portfolio, ranked #111.

Founders Grove Wealth Partners first reported a position in ABT in Q4 2024 and has held it in 7 quarters since. The position peaked at $624K in Q3 2025. 2,968 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

  • Founders Grove Wealth Partners held 5,342 shares of Abbott worth $485K as of Q2 2026.
  • Founders Grove Wealth Partners bought 145 Abbott shares in Q2 2026, an estimated $13.2K.
  • Abbott made up 0.1% of Founders Grove Wealth Partners's portfolio in Q2 2026, its #111 holding.
  • Founders Grove Wealth Partners first reported a position in Abbott in Q4 2024 and has held it in 7 quarters since.
  • Founders Grove Wealth Partners's Abbott position peaked at $624K in Q3 2025.
  • 2,968 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on Founders Grove Wealth Partners's 13F filing for Q2 2026, filed 22 Jul 2026.